- Reported purity
- 99.92%99.5%+
- Test date
- Jul 30, 2026
- Laboratory named
- ILS Laboratories
Lot details
THA0001
Loading peptide prices…
Loading peptide prices…
Compare observed vial prices, price per mg, and current indexed COA records across vendors.
Indexed documents do not establish product quality. Missing means we have not indexed one. Index as of Aug 2026.
Some outbound vendor links are affiliate links. Commission status does not change the displayed prices, indexed COA fields, or certificate filters.
Observed market data
Document coverage, not product quality.
Observed Thymosin Alpha-1 listings span $29.99-$424.10 in total vial price, with a median of $8 per mg across 86 usable listings as of Aug 30, 2026. Compare observed Thymosin Alpha-1 vial listings by total price, price per mg, vial size, stock status, and last-checked date. This market view does not recommend a seller or verify a product for clinical use. Observed vial prices do not include clinician visits, pharmacy compounding, injection supplies, shipping, or other treatment-related costs. Each vendor row shows its current COA record, including the reported purity, named lab, and printed test date.
Observed Thymosin Alpha-1 listings span $29.99-$424.10 in total vial price, with a median of $8 per mg across 86 usable listings as of Aug 30, 2026.
The comparison covers observed vial prices and price per mg. Observed vial prices do not include clinician visits, pharmacy compounding, injection supplies, shipping, or other treatment-related costs.
The index has a current certificate on file for 44 of 69 tracked Thymosin Alpha-1 vendors, with 139 public documents. Vendors may have testing that we have not indexed.
Choose “Highest COA purity” to sort vendors by the value printed on each current certificate. The number belongs to that document, lab, lot, and test date. It cannot establish product quality or safety, and values from different labs or methods are not directly comparable.
Product documentation
Current certificates are on file for 44 of 69 tracked vendors. The public evidence set contains 139 documents naming 12 laboratories. Reported test dates in this set run from Jan 7, 2024 through Jul 30, 2026.
25 tracked vendors have no current certificate in this index. Those vendors may have testing we have not indexed.
44 current records
THA0001
TA0404
Red Cap
THY10001
ULP-36004A
TA1-05
GB0006YF
TUY-060326
PH-ta110-0509
TA1006222026
AMP-TA11006052026-04
EZP-TA11006052026-04
Black Cap
982444TU
B002
PP2602-041A
TA05260910H
3548699
33-05260828
11248-SG5
TA1-010-MH-02
TAXV042603
C73756
Black Cap
2026-03-30
TA10-03232026
BX-JH906
2026-02-27 (Vial 1)
1670
TA202082
0012600
8201947365
25-3013
FP25-0082
TY10/2025-04
2024010701
20200519027
A record appears on file after our pipeline identifies the document as a certificate of analysis and matches its printed compound to a catalog peptide. The record cannot prove authenticity, chain of custody, sterility, product safety, or suitability for use.
Lab, lot, date, compound, and purity fields are transcribed from the document and can contain extraction errors. “Older record” means the reported test date is more than 18 months old.
Learn how to read a peptide COA or review the testing methodology and dataset.